HIGHLIGHTS
- who: . and collaborators from the Tai`an City Central Hospital, China University, China have published the Article: Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma, in the Journal: (JOURNAL)
- what: The aim of this study was to identify cuproptosis-related genes associated with poor prognosis of HNSCC and screen for potential candidate drugs for its treatment using molecular docking and molecular dynamics simulations. Based on molecular dynamics simulations, this study shows that plicamycin targets CDKN2A to improve patient outcomes. In this study, CDKN2A . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.